Diabetes, Vol 45, Issue 9 1204-1208, Copyright © 1996 by American Diabetes Association

ARTICLES

A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM

DG Fogarty, JC Harron, AE Hughes, NC Nevin, CC Doherty and AP Maxwell
Regional Nephrology Unit, Belfast City Hospital, Northern Ireland.

Recent studies have suggested that an inherited predisposition to essential hypertension may increase susceptibility to nephropathy for patients with IDDM. Essential hypertension has been linked to the angiotensinogen (AGT) gene in genetic linkage studies in American and European populations. A molecular variant (M235T), which has a functional effect, has been described with highest plasma AGT levels being associated with the TT genotype. In a case-control study, we have evaluated the role of this functional genetic marker in patients with IDDM and nephropathy and in IDDM patients without nephropathy. We studied 195 IDDM patients, of whom 95 had established diabetic nephropathy; the remaining 100 patients, who had no evidence of microalbuminuria, served as control subjects. All patients were whites born in Northern Ireland. The point mutation in the AGT gene was analyzed using restriction typing. The background frequency of the M235T variant was assessed in 80 healthy blood donors, and the TT genotype was present in 9%. This genotype occurred in 8% of control IDDM patients without nephropathy and 19% of IDDM patients with nephropathy (P = 0.025). The odds ratio for diabetic nephropathy associated with the TT genotype was 2.7 (95% CI 1.04-7.52). There was no relationship between blood pressure and AGT genotypes in the control group. We cannot exclude the possibility that the observed association in the nephropathy group is due to an association between AGT genotype and hypertension. This evidence may help to explain the predisposition to diabetic nephropathy afforded by hypertension and merits further investigation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]

				B. R. Conway, R. Martin, A.-J. McKnight, D. A. Savage, H. R. Brady, and A. P. Maxwell Role of {alpha}-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2019 - 2024. [Abstract] [Full Text] [PDF]

				B. R. Conway, A. P. Maxwell, D. A. Savage, C. C. Patterson, P. P. Doran, M. Murphy, H. R. Brady, and D. G. Fogarty Association Between Variation in the Actin-Binding Gene Caldesmon and Diabetic Nephropathy in Type 1 Diabetes Diabetes, April 1, 2004; 53(4): 1162 - 1165. [Abstract] [Full Text] [PDF]

				K. Susztak, K. Sharma, M. Schiffer, P. McCue, E. Ciccone, and E. P. Bottinger Genomic Strategies for Diabetic Nephropathy J. Am. Soc. Nephrol., August 1, 2003; 14(90003): S271 - 278. [Abstract] [Full Text] [PDF]

				M. C. Lansang and N. K. Hollenberg Renal Perfusion and the Renal Hemodynamic Response to Blocking the Renin System in Diabetes: Are the Forces Leading to Vasodilation and Vasoconstriction Linked? Diabetes, July 1, 2002; 51(7): 2025 - 2028. [Abstract] [Full Text] [PDF]

				M. J. Zychma, E. Zukowska-Szczechowska, B. I. Lacka, and W. Grzeszczak Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1965 - 1970. [Abstract] [Full Text] [PDF]

				F. J. van Ittersum, A. M. E. de Man, S. Thijssen, P. de Knijff, E. Slagboom, Y. Smulders, L. Tarnow, A. J. M. Donker, H. J. G. Bilo, and C. D. A. Stehouwer Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1000 - 1007. [Abstract] [Full Text] [PDF]

				J. Deinum, L. Tarnow, J. M. van Gool, R. A. de Bruin, F. H. M. Derkx, M. A. D. H. Schalekamp, and H.-H. Parving Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1904 - 1911. [Abstract] [Full Text] [PDF]

				T. Niu, J. Yang, B. Wang, W. Chen, Z. Wang, N. Laird, E. Wei, Z. Fang, K. Lindpaintner, J. J. Rogus, et al. Angiotensinogen Gene Polymorphisms M235T/T174M : No Excess Transmission to Hypertensive Chinese Hypertension, February 1, 1999; 33(2): 698 - 702. [Abstract] [Full Text] [PDF]

				M. B. S. Freire, L. Ji, T. Onuma, T. Orban, J. H. Warram, and A. S. Krolewski Gender-Specific Association of M235T Polymorphism in Angiotensinogen Gene and Diabetic Nephropathy in NIDDM Hypertension, April 1, 1998; 31(4): 896 - 899. [Abstract] [Full Text] [PDF]

				J. J. Rogus, D. Moczulski, M. B. S. Freire, Y. Yang, J. H. Warram, and A. S. Krolewski Diabetic Nephropathy Is Associated With AGT Polymorphism T235 : Results of a Family-Based Study Hypertension, February 1, 1998; 31(2): 627 - 631. [Abstract] [Full Text] [PDF]

				P. Corvol and X. Jeunemaitre Molecular Genetics of Human Hypertension: Role of Angiotensinogen Endocr. Rev., October 1, 1997; 18(5): 662 - 677. [Abstract] [Full Text]